Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)

CompletedOBSERVATIONAL
Enrollment

565

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 12, 2022

Study Completion Date

December 12, 2022

Conditions
EpilepsyPregnancy
Trial Locations (20)

15213

University of Pittsburgh Medical Center, Pittsburgh

27157

Wake Forest Baptist Health-Wake Forest University School of Medicine, Winston-Salem

30322

Emory University School of Medicine, Atlanta

33136

University of Miami Hospital - University of Miami School of Medicine, Miami

55113

Minnesota Epilepsy Group, Roseville

60611

Northwestern Memorial Hospital-Northwestern University Feinberg School of Medicine, Chicago

90089

Keck Hospital of the University of Southern California, Los Angeles

94305

Stanford University, Stanford

98104

University of Washington Medical Center, Seattle

35294-0021

University of Alabama Birmingham Hospital- UAB, Birmingham

85724-5023

University of Arizona - University Medical Center, Tucson

30912-0004

Medical College of Georgia at Georgia Regents University, Augusta

21224-2735

John Hopkins Bayview Medical Center, Baltimore

02115-6110

Brigham & Women's Hospital - Harvard, Boston

48202-2608

Henry Ford Hospital, Detroit

11040-1402

North Shore Jewish Medical Center, Manhasset

10016-6402

New York University School of Medicine, New York

10032-7133

Columbia University Medical Center/NY Presbyterian Hospital, New York

45267-0525

University of Cincinnati UC Health University Hospital, Cincinnati

17822-9800

Geisinger Medical Center, Danville

All Listed Sponsors
collaborator

The Emmes Company, LLC

INDUSTRY

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Stanford University

OTHER

NCT01730170 - Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) | Biotech Hunter | Biotech Hunter